Targeting rapid TKI-induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia
Mol Oncol. 2024 Oct 12. doi: 10.1002/1878-0261.13749. Online ahead of print. ABSTRACT Acute myeloid leukemia (AML) patients with the FMS-related receptor tyrosine kinase 3 internal …